Even if the central government and the National Pharmaceutical Pricing Authority were to control prices of all the medical devices recommended by the state drug authorities of Maharashtra and Odisha, it would barely cover 15% of India's medical device market estimated to be worth approximately Rs 25,000 crore in 2015 and projected to double by 2020.

The devices recommended for price control fall into two categories -consumables, which includes syringes, cath eters, sutures and face masks; and patient aids, which includes stents, orthopaedic implants, pacemakers and so on....................Read more

Source: The Times of India